title: Tolerance to propofol's sedative effect in mechanically ventilated Rabbits.
abstract: Propofol is commonly used for the sedation of critically ill patients undergoing mechanical ventilation. These patients may develop tolerance during long-term administration. Here, we describe the development of tolerance to propofol's sedative effect in rabbits during prolonged mechanical ventilation. Six healthy male New Zealand White rabbits were endotracheally intubated and received propofol by continuous IV infusion to maintain sedation for 48 h. The propofol infusion rate (IR) was adjusted to maintain the desired level of sedation. Assessments of the sedation level were made every 30 min or earlier if there were signs of awakening. Propofol concentrations were measured in arterial plasma after every other IR adjustment, provided there was an adequate level of sedation, using high performance liquid chromatography, and calculations of systemic clearance rates were made. The mortality rate was 100% with a survival period of 30.8 +/- 6.0 h (mean +/- sd). The course of IR adjustments followed a 5-phase pattern: 1) steady IR (mean +/- sd duration; 1.2 +/- 0.6 h), 2) increasing IR (9.4 +/- 5.5 h), 3) steady high-IR (2.3 +/- 1.2 h), 4) decreasing IR (13.7 +/- 1.9 h), and 5) steady low-IR (5.0 +/- 2.7 h). The course of propofol concentrations during the experiment in relation to propofol IR followed a 3-phase pattern: 1) steady concentration with increasing IRs (6.0 +/- 2.7 h), 2) increasing concentrations with increasing IR (5.8 +/- 2.5 h), and 3) increasing concentrations with decreasing IR (18.8 +/- 3.3 h). Propofol systemic clearance rates were progressively increased for 6.0 +/- 2.7 h and then gradually decreased for 24.6 +/- 4.7 h. In conclusion, all rabbits developed tolerance to propofol's sedative effect within the first hours of administration related to changes to the drug's metabolic clearance.
authors.affiliation: Laboratory of Experimental Surgery and Surgical Research, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. pipsil@med.duth.gr
authors.forename: Petros
authors.initials: P
authors.lastname: Ypsilantis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Mikroulis
authors.forename: Maria
authors.initials: M
authors.lastname: Politou
authors.forename: Heleni
authors.initials: H
authors.lastname: Tsoukali
authors.forename: Michail
authors.initials: M
authors.lastname: Pitiakoudis
authors.forename: Vasilios
authors.initials: V
authors.lastname: Didilis
authors.forename: Georgios
authors.initials: G
authors.lastname: Theodoridis
authors.forename: Georgios
authors.initials: G
authors.lastname: Bougioukas
authors.forename: Constantinos
authors.initials: C
authors.lastname: Simopoulos
mesh_terms: D000818:Animals; D004361:Drug Tolerance; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D008657:Metabolic Clearance Rate; D015742:Propofol / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D011817:Rabbits; D012121:Respiration, Artificial
chemical_list: D006993:Hypnotics and Sedatives; D015742:Propofol